As part of our 2020-2025 strategy, we are making positive interventions to embed the ethos of diversity, equity and inclusion into policies, processes and everyday practice, working to eliminate barriers to participation and success.
As an international network, people are at the heart of everything we do. As such, face-to-face meetings are essential for us, and travelling has always been a distinctive feature of our approach. While it provides numerous advantages in terms of delivering global impact, such as facilitating research, exchange of ideas and improving partnerships, it also contributes to our annual carbon footprint.
In over 30 years of successful activities for our network, we have built an ever-increasing portfolio of projects. This includes not only clinical trials, but also large observational and cohort studies and pregnancy studies, supported by an expanding basic science platform and training and educational programmes across the world.
Following previous trends, HIV remains a key element in the research activities of the Foundation. However, the COVID-19 pandemic led to new collaborations and projects, opening a new research area. At the same time, antimicrobials and network building still represent a considerable share of Penta’s activities. Additionally, the use of resources is mainly directed to project-related activities, especially the implementation of clinical trials and cohort studies in which the Foundation is involved. In 2022, the Foundation received funding from an array of sources, mostly from private and international institutions showing the numerous collaborations the Foundation has in place.
The chart shows the percentage distribution of the use of resources by type of activity for 2022. As shown, most of the expenses were incurred in relation to the implementation of clinical trials and cohort studies, highlighting the numerous studies the foundation is running.
Download Penta Foundation’s 2022 Balance Sheet
As we set our sights on the years ahead, we are looking forward to: